Description

Singulair (Montelukast) Chewable Tablets 4 mg. №28

Ingredients

Active ingredient: Montelukast sodium.
Other ingredients: Mannitol, microcrystalline cellulose, hydroxypropyl cellulose, red ferric oxide, croscarmellose sodium, cherry flavor, aspartame, and magnesium stearate.

Dosage

Recommended dosage: 4 mg once daily in the evening for children 2 to 5 years of age.

Indications

Singulair Chewable Tablets are indicated for the prophylaxis and chronic treatment of asthma in pediatric patients aged 2 to 5 years.

Contraindications

Do not use Singulair Chewable Tablets if you are allergic to any of the ingredients in the product.

Directions

Chew the tablet completely before swallowing. It can be taken with or without food. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Montelukast, the active ingredient in Singulair, is a leukotriene receptor antagonist that works by blocking leukotrienes. Leukotrienes are chemicals in the body that can cause asthma symptoms. Clinical studies have shown that montelukast is effective in improving asthma symptoms and reducing the frequency of asthma attacks in pediatric patients.

Additional Information

It is important to note that Singulair Chewable Tablets are not meant to treat acute asthma attacks but rather to prevent them. Always carry a rescue inhaler for sudden asthma symptoms. Consult your healthcare provider for more information on asthma management and treatment options.

Montelukast has been extensively studied in clinical trials, demonstrating its safety and efficacy in pediatric asthma management. Research published in the Journal of Pediatrics has highlighted the role of montelukast in improving lung function and reducing asthma exacerbations in children.

Overall, Singulair Chewable Tablets offer a convenient and effective option for pediatric asthma management, backed by scientific evidence and clinical trials.